Mar. 27, 2026
Sonorous NV Announces Leadership Transition
Medical device company appoints new CEO and Chairman of the Board
Mar. 27, 2026
Novartis to acquire Excellergy for up to $2 billion
Acquisition to advance potentially first-in-class trifunctional effector cell response inhibitors for severe allergies
Mar. 27, 2026
Novartis to Acquire Excellergy in $2 Billion Deal
The acquisition will strengthen Novartis' portfolio of treatments for food allergies and other immunology conditions.
Mar. 24, 2026
Surrozen Reports Q4 and Full Year 2025 Financial Results, Provides Business Update
Company expects to submit IND for SZN-8141 in second half of 2026, plans ARVO presentation on retinal vascular research
Mar. 24, 2026
Biotechs Must Face Reality To Succeed in Today's Funding Environment
The biotech industry needs to stop waiting for a rebound and adapt to the new market realities.
Mar. 21, 2026
Kaiser Permanente Nurses Ratify Contracts After Year of Strikes
Agreements include 21.5% wage increases and strengthened staffing protections
Mar. 21, 2026
Halozyme Touts $1.8B Revenue Outlook, Expanding Subcutaneous Drug Delivery
Biopharmaceutical company highlights growth from ENHANZE royalties and new collaboration deals at industry conference.
Mar. 19, 2026
RxSafe and LTC@Home Pharmacy Network Launch LTC@Vantage Bundle
New offering aims to help independent pharmacies scale long-term care at home services more efficiently.
Mar. 19, 2026
Vesicor Therapeutics Appoints Michael Tolentino, M.D., as Chief Executive Officer
Accomplished biotech leader to lead Vesicor as it pursues IND submission for its cancer therapeutic
Mar. 18, 2026
Evolus Raises 2028 Revenue Targets as Toxin Market Stabilizes, Evolysse Gains Traction
Aesthetics company sees signs of improvement in botulinum toxin market and slower recovery for dermal fillers
Mar. 17, 2026
Veteran Nurse Sues Elevance Health for Firing Her Over Disability
Lawsuit alleges healthcare giant discriminated against longtime employee with debilitating nerve condition
Mar. 17, 2026
GE HealthCare Highlights Supply Chain Moves, Downplays Middle East Exposure
Executives say company's direct business in the region is less than 5% of overall operations.
Mar. 16, 2026
Latham & Watkins Rehires Healthcare Partner From Fenwick in LA
Jennifer Yoo rejoins the firm's healthcare and life sciences practice.
Mar. 15, 2026
Cytokinetics Previews Upcoming Phase 3 ACACIA-HCM Readout, Highlights Myqorzo Launch Traction
Biotech firm provides updates on its cardiac myosin inhibitor pipeline at Citi conference
Mar. 14, 2026
Webinar to Demystify UR and IMR in California Workers' Comp
Experts to Discuss Strategies for Securing Medical Treatment Approvals
Mar. 14, 2026
Coherus Oncology Pivots to Immuno-Oncology, Touts LOQTORZI Growth and New Pipeline at Citizens Conf.
Company outlines transition to innovative oncology company focused on overcoming immune resistance in cancer.
Mar. 13, 2026
BridgeBio Touts Attruby Uptake, Bayer's Europe Rollout, and Pipeline Timelines
Company highlights accelerating U.S. patient adds, international expansion, and upcoming milestones at Leerink conference.
Mar. 13, 2026
GRAIL Announces CEO Retirement and Successor Appointment
Bob Ragusa to retire as CEO, Josh Ofman, MD, MSHS, named as new CEO
Mar. 13, 2026
Inovio Shareholders Urged to File Lawsuit Over Securities Fraud
Deadline Alert: Investors Who Lost Money on Inovio Stock Encouraged to Contact Law Firm About Class Action
Mar. 12, 2026
SK pharmteco Qualifies Commercial-Scale Viral Vector Facility in France
New state-of-the-art plant in Corbeil-Essonnes now fully operational to support late-stage and commercial viral vector programs.
